Patients receiving induction chemotherapy followed by EPP for malignant pleural mesothelioma ...showed a median survival of 22 months.
Raleigh, NC (PRWEB) September 07, 2015
Doctors in Switzerland have released a proposed way of scoring mesothelioma patients based on their likelihood of responding well to multimodal therapy with chemotherapy and surgery. Surviving Mesothelioma has just posted an article on the new research. Click here to read it now.
Scientists at University Hospital Zurich evaluated the cases of 128 mesothelioma patients who underwent chemotherapy followed by extrapleural pneumonectomy (EPP) surgery between 1999 and 2011.
According to study author Isabelle Opitz, MD, with the University Hospital Zurich Division of Thoracic Surgery, “Patients receiving induction chemotherapy followed by EPP for malignant pleural mesothelioma of all histological subtypes and irrespective of nodal status showed a median survival of 22 months.”
This survival rate, detailed in the Journal of Thoracic Oncology, was about twice as long as it was among mesothelioma patients who did not undergo surgery.
“The decision of whether or not to undergo radical mesothelioma surgery is an enormous one. Having a prognostic score, as this study suggests, could make the process easier for both patients and doctors,” says Alex Strauss, Managing Editor of Surviving Mesothelioma.
Read the details of the study including the criteria used to develop the new prognostic score in Prognostic 'Score' May Help Pick Candidates for Mesothelioma Surgery, now available on the Surviving Mesothelioma website.
Opitz, I, “A new prognostic score supporting treatment allocation for multimodality therapy for malignant pleural mesothelioma- A review of 12 years' experience”, August 27, 2015, Journal of Thoracic Oncology, Epub ahead of print, http://www.researchgate.net/publication/281337063
For nearly ten years, Surviving Mesothelioma has brought readers the most important and ground-breaking news on the causes, diagnosis and treatment of mesothelioma. All Surviving Mesothelioma news is gathered and reported directly from the peer-reviewed medical literature. Written for patients and their loved ones, Surviving Mesothelioma news helps families make more informed decisions.